Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LITHOS asthma efficacy and safety study
2021-003334-36Phase 3Withdrawn
- Sponsor
- AstraZeneca
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Budesonide + formoterol fumarate MDI with Budesonide MDI (2 arms). Planned start Nov 2022; status: withdrawn.
02
Drugs
budesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2021-003334-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003334-36.